Author: Dyer, Wayne B; Zaunders, John J; Yuan, Fang Fang; Wang, Bin; Learmont, Jennifer C; Geczy, Andrew F; Saksena, Nitin K; McPhee, Dale A; Gorry, Paul R; Sullivan, John S
Title: Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection Document date: 2008_12_11
ID: 0ddutmdd_22
Snippet: From all reported TAHIV cases from the state of NSW, Australia, a cohort of 13 (10%) remained asymptomatic after 10 years of infection. We now report that only 5 remain non-progressors after 23 to 26 years of HIV-1 infection. Infection and treatment history for each subject is summarised in Additional file 1. Most of these individuals had a survival advantage, with 7 of 13 having at least one host genetic polymorphism associated with slow progres.....
Document: From all reported TAHIV cases from the state of NSW, Australia, a cohort of 13 (10%) remained asymptomatic after 10 years of infection. We now report that only 5 remain non-progressors after 23 to 26 years of HIV-1 infection. Infection and treatment history for each subject is summarised in Additional file 1. Most of these individuals had a survival advantage, with 7 of 13 having at least one host genetic polymorphism associated with slow progression, and 6 of 13 were infected with the SBBC nefdefective HIV-1 strain [12] , and combined, 12 of 13 had at least one host or viral factor favouring slow progression. Acting in opposition to these survival advantages, 5 of 8 former non-progressors had the FcγRIIA polymorphism (R/R). While this genotype was absent in current LTNP, the effect of the R/R genotype in promoting disease progression was not significant in this small study of 13 individuals. On balance, these competing survival factors along with antiviral immune responses enabled a nonprogressive disease course to be established early in infection.
Search related documents:
Co phrase search for related documents- additional file and disease course: 1, 2, 3, 4
- additional file and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- additional file and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9
- additional file and non progressor: 1, 2
- additional file and small study: 1, 2
- additional file and treatment infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- antiviral immune response and disease course: 1, 2
- antiviral immune response and disease progression: 1, 2, 3, 4, 5, 6, 7
- antiviral immune response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77
- antiviral immune response and small study: 1
- antiviral immune response and treatment infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- antiviral immune response and viral factor: 1, 2
Co phrase search for related documents, hyperlinks ordered by date